1st Quarter - Report
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Firm
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Bilirakis) |
Health Issues HCR
General health care issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.